Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis

Mol Cell Biochem. 1999 Sep;199(1-2):169-78. doi: 10.1023/a:1006980326855.

Abstract

Recent studies have suggested that MAP kinase phosphatase 1 (MKP-1) is overexpressed in prostate cancer. To evaluate the role of MKP-1 in regulating cell death and tumor growth in prostate cancer, MKP-1 was conditionally overexpressed in the human prostate cancer cell line DU145. Overexpression of MKP-1 in DU145 cells blocked activation of stress-activated protein kinase (SAPK/JNK). MKP-1 overexpression in DU-145 cells was also found to inhibit Fas ligand (FasL)-induced apoptosis, as well as block the activation of caspases by Fas engagement. In addition, MKP-1 blocked the activation of apoptosis by transfected MEKK-1 and ASK-1, presumably through its inhibition of the SAPK/JNK family of enzymes. MKP-1 blocked the ability of FasL to induce loss of mitochondrial transmembrane potential (delta Psi(m)), suggesting that MKP-1 acts upstream of mitochondrial pro-apoptotic events induced by FasL and that the SAPK/JNK pathway may form the signaling link between Fas receptor and mitochondrial dysfunction. Thus, MKP-1 overexpression in prostate cancer may play a role in promoting prostate carcinogenesis by inhibiting FasL-induced cell death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apoptosis*
  • Caspases / metabolism
  • Cell Cycle Proteins*
  • Dual Specificity Phosphatase 1
  • Enzyme Activation
  • Fas Ligand Protein
  • Humans
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / metabolism*
  • MAP Kinase Kinase Kinase 1*
  • MAP Kinase Kinase Kinase 5
  • MAP Kinase Kinase Kinases / metabolism
  • Male
  • Membrane Glycoproteins / metabolism*
  • Membrane Potentials
  • Metallothionein / genetics
  • Mitochondria / metabolism*
  • Mitogen-Activated Protein Kinase 10
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphoprotein Phosphatases*
  • Promoter Regions, Genetic
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Protein Phosphatase 1
  • Protein Serine-Threonine Kinases*
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / metabolism*
  • Protein-Tyrosine Kinases / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Tumor Cells, Cultured

Substances

  • Cell Cycle Proteins
  • FASLG protein, human
  • Fas Ligand Protein
  • Immediate-Early Proteins
  • Membrane Glycoproteins
  • Recombinant Proteins
  • Metallothionein
  • Mitogen-Activated Protein Kinase 10
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 1
  • MAP Kinase Kinase Kinase 5
  • MAP Kinase Kinase Kinases
  • MAP3K1 protein, human
  • MAP3K5 protein, human
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1
  • Protein Tyrosine Phosphatases
  • Caspases